| Notice Filed with SOS |
07/15/2022 |
| Rule |
ProposedRuleAttach2022-00382.doc |
| Statutory Authority |
10-16-1403(5) and 10-16-1406, C.R.S. |
| Description of Subjects/Issues |
The purpose of this part 3 is to establish a methodology and process for the Board to annually identify and select prescription drugs eligible for affordability review and conduct affordability reviews of prescription drugs to determine whether use of the prescription drug consistent with the labeling approved for the prescription drug by the FDA or with standard medical practice is unaffordable for Colorado consumers pursuant to section 10-16-1406(3), C.R.S. |
| Purpose/Objective of Rule |
The purpose of this part 3 is to establish a methodology and process for the Board to annually identify and select prescription drugs eligible for affordability review and conduct affordability reviews of prescription drugs to determine whether use of the prescription drug consistent with the labeling approved for the prescription drug by the FDA or with standard medical practice is unaffordable for Colorado consumers pursuant to section 10-16-1406(3), C.R.S. |
| Submitted in response to issues raised by COLS/OLLS? |
No
|
| Is this rule adopted in response to recent legislation? |
No
|
| Hearing Date |
08/26/2022 |
| Hearing Time |
10:00 AM |
| Hearing Location |
Webinar or 1560 Broadway, STE 850, Denver CO 80202 |
| Contact Name |
Jill Mullen |
| Contact Title |
Policy Advisor |
| Contact Telephone |
720-5564952 |
| Contact email |
jill.mullen@state.co.us |